KCNK13
KCNK13[edit]

KCNK13 is a member of the two-pore domain potassium channel family, which are integral membrane proteins that contribute to the regulation of the resting membrane potential in cells. These channels are characterized by having two pore-forming domains and are known for their role in setting the background potassium conductance in various tissues.
Structure[edit]
KCNK13, like other members of the K2P channel family, contains four transmembrane segments and two pore-forming domains. This unique structure allows the channel to conduct potassium ions across the cell membrane, contributing to the maintenance of the cell's resting potential. The channel is thought to form dimers, with each subunit contributing to the formation of the pore.
Function[edit]
The primary function of KCNK13 is to facilitate the passive flow of potassium ions across the cell membrane. This flow is crucial for maintaining the resting membrane potential and for the regulation of neuronal excitability. KCNK13 channels are also involved in various physiological processes, including cell volume regulation and apoptosis.
Expression[edit]
KCNK13 is expressed in a variety of tissues, with notable expression in the central nervous system. Its expression pattern suggests a role in modulating neuronal activity and maintaining the excitability of neurons. The channel is also found in other tissues, indicating potential roles in non-neuronal physiological processes.
Clinical Significance[edit]
Alterations in the function or expression of KCNK13 have been implicated in several pathological conditions. Dysregulation of KCNK13 activity can affect neuronal excitability, potentially contributing to neurological disorders such as epilepsy and depression. Research is ongoing to better understand the role of KCNK13 in these and other conditions.
Related pages[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian